← Main Index Directory
Wolverine Stack Assay Protocol
In-Vitro ArchitectureDelivery & Half-Life Parameters
Validated Mapping Vector: Subcutaneous injection vectors. Blended before application or drawn from individual material sources.
Biological Half-Life Metric: Split tracking required due to BPC-157's fast clearing window and TB-500's extended systemic persistence.
Recommended In-Vitro Dosing Architecture
Simultaneous protocol: BPC-157 at 250mcg-500mcg twice daily (BID), coupled with TB-500 loaded at 2.5mg twice per week.
Standard Target Observation Timelines
Maintained across a unified 6 to 8-week testing track to evaluate total matrix structural recovery.